PDL BIOPHARMA INC | 6,407 Euro | -0,002 -0,03 % | |
| WKN: A0H1J1 ISIN: US69329Y1047 Ticker-Symbol: PDL | Frankfurt | 24.05.13 | 10:09 Uhr |
Branche PharmaAktienmarkt NASDAQ Biotech |
|
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 22.05. | PDL BIOPHARMA, INC. - 8-K, Current Report | 8 | SEC Filings | |
| 13.05. | PDL BioPharma Misses Earnings Ests | 23 | Zacks | |
| 10.05. | PDL BioPharma CEO Discuses Q1 2013 Results - Earnings Call Transcript | 13 | Seeking Alpha | |
| 09.05. | PDL BioPharma Q1 Profit Tops View | 94 | AFX News | |
| WASHINGTON (dpa-AFX) - PDL BioPharma Inc. (PDLI) Thursday reported
first-quarter net income of $53.5 million or $0.36 per share, compared with
$40.2 million or $0.29 per share last year.The... Mehr lesen zu: PDL BioPharma Q1 Profit Tops View | ||||
| 09.05. | PDL BioPharma Announces First Quarter 2013 Financial Results | 47 | PR Newswire | |
| INCLINE VILLAGE, Nev., May 9, 2013 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today reported financial results for the first quarter ended March 31, 2013.
(Logo: http://photos.prnewswire.com/prnh/20110822/SF55808LOGO)... Mehr lesen zu: PDL BioPharma Announces First Quarter 2013 Financial Results | ||||
| 09.05. | Whisper Number Impact: Earnings Preview For PDL BioPharma | 4 | Seeking Alpha | |
| 08.05. | PDL BioPharma has the Highest Forward Earnings Yield in the Biotechnology Industry | 7 | SmarTrend | |
| 06.05. | PDL BioPharma is Among the Companies in the Biotechnology Industry With the Highest Operating Margin | 8 | SmarTrend | |
| 02.05. | PDL BioPharma to Announce First Quarter 2013 Financial Results on May 9, 2013 | 55 | PR Newswire | |
| INCLINE VILLAGE, Nev., May 2, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company will release its first quarter 2013 financial results for... Mehr lesen zu: PDL BioPharma to Announce First Quarter 2013 Financial Results on May 9, 2013 | ||||
| 01.05. | PDL BioPharma Names Peter Garcia CFO | 45 | AFX News | |
| WASHINGTON (dpa-AFX) - PDL BioPharma, Inc. (PDLI) said Tuesday that it has
appointed Peter Garcia to the position of vice president, chief financial
officer and acting chief accounting officer... Mehr lesen zu: PDL BioPharma Names Peter Garcia CFO | ||||
| 30.04. | PDL BioPharma Appoints Peter Garcia as Chief Financial Officer | 36 | PR Newswire | |
| INCLINE VILLAGE, Nev., April 30, 2013 /PRNewswire/ --PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that the Company has appointed Peter S. Garcia to the position of vice president, chief... Mehr lesen zu: PDL BioPharma Appoints Peter Garcia as Chief Financial Officer | ||||
| 23.04. | PDL BioPharma to Finance Avinger | 5 | Zacks | |
| 22.04. | PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger | 56 | PR Newswire | |
| INCLINE VILLAGE, Nev., April 22, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) and Avinger, Inc. announced today that they closed a structured financing and royalty transaction... Mehr lesen zu: PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger | ||||
| 22.04. | PDL BioPharma (PDLI) Enters $40M Financing Agreement w/ Avinger | 1 | StreetInsider.com | |
| 22.04. | Avinger, PDL Biopharma Close on $40M Structured Financing and Royalty Transaction | 1 | Benzinga.com | |
| 22.04. | Avinger, PDL BioPharma Close Mezzanine Financing | - | Benzinga.com | |
| 22.04. | PDL BIOPHARMA, INC. - 8-K, Entry into a Material Definitive Agreement Creation of ... | 3 | SEC Filings | |
| 10.04. | PDL BioPharma has the Lowest EV/EBITDA Ratio in the Biotechnology Industry | 12 | SmarTrend | |
| 08.04. | Relatively High Forward Earnings Yield Detected in Shares of PDL BioPharma in the Biotechnology Industry | 7 | SmarTrend | |
| 04.04. | Shares of PDL BioPharma Rank the Highest in Terms of Operating Margin in the Biotechnology Industry | 3 | SmarTrend | |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| VERTEX PHARMACEUTICALS | 59,50 | -1,53 % | OCZ kündigt SSD-Reihe Vertex 450 mit 20-Nanometer-NAND-Flash an |
| STADA ARZNEIMITTEL | 34,05 | +0,43 % | Stada: Deutsche Bank zeigt Interesse |
| GILEAD SCIENCES | 43,045 | +0,10 % | Maximieren Sie Ihren Ertrag in nur 30 Minuten! (Freenet +370% / Technotrans +100% / Gilead +120% ...) |
| CELGENE | 94,61 | -1,50 % | Celgene Announces U.S. FDA Grants Priority Review for ABRAXANE sNDA in Advanced Pancreatic Cancer |
| PFIZER | 22,452 | -0,10 % | Pfizer spaltet Tierarzneisparte Zoetis endgültig ab |
